Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1997-8-7
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0163-4453
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
158
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9138144-Antibodies, Viral,
pubmed-meshheading:9138144-Clinical Trials as Topic,
pubmed-meshheading:9138144-Hepatitis A,
pubmed-meshheading:9138144-Hepatitis A Vaccines,
pubmed-meshheading:9138144-Hepatovirus,
pubmed-meshheading:9138144-Humans,
pubmed-meshheading:9138144-Vaccines, Inactivated,
pubmed-meshheading:9138144-Viral Hepatitis Vaccines
|
pubmed:year |
1997
|
pubmed:articleTitle |
Persistence of antibodies after inactivated hepatitis A vaccines in a comparative study.
|
pubmed:publicationType |
Letter
|